EA201100001A3 - Нуклеотиды и нуклеозиды и методы их использования в секвенировании днк - Google Patents

Нуклеотиды и нуклеозиды и методы их использования в секвенировании днк

Info

Publication number
EA201100001A3
EA201100001A3 EA201100001A EA201100001A EA201100001A3 EA 201100001 A3 EA201100001 A3 EA 201100001A3 EA 201100001 A EA201100001 A EA 201100001A EA 201100001 A EA201100001 A EA 201100001A EA 201100001 A3 EA201100001 A3 EA 201100001A3
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
cleavable
dna
nucleosides
nucleotides
Prior art date
Application number
EA201100001A
Other languages
English (en)
Other versions
EA201100001A2 (ru
Inventor
Владислав А. Лайташ
Меган Н. Хёш
Брайэн П. Стьюпи
Вэйданг Ву
Майкл Л. Метзкер
Original Assignee
Лейзеджен, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лейзеджен, Инк. filed Critical Лейзеджен, Инк.
Publication of EA201100001A2 publication Critical patent/EA201100001A2/ru
Publication of EA201100001A3 publication Critical patent/EA201100001A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/117—Modifications characterised by incorporating modified base
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Данное изобретение в целом относится к меченым и не помеченным расщепляемым терминирующим группам и методам для ДНК-секвенирования и других типов ДНК-анализа. В частности, изобретение относится к нуклеотидам и нуклеозидам с химически расщепляемыми, фоторасщепляемыми, ферментно расщепляемыми или нефоторасщепляемыми группами и методам их использования в ДНК-секвенировании и применению в биомедицинских исследованиях.
EA201100001A 2008-06-11 2009-06-11 Нуклеотиды и нуклеозиды и методы их использования в секвенировании днк EA201100001A3 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6079508P 2008-06-11 2008-06-11
US18477909P 2009-06-05 2009-06-05
PCT/US2009/047071 WO2009152353A2 (en) 2008-06-11 2009-06-11 Nucleotides and nucleosides and methods for their use in dna sequencing

Publications (2)

Publication Number Publication Date
EA201100001A2 EA201100001A2 (ru) 2012-10-30
EA201100001A3 true EA201100001A3 (ru) 2013-03-29

Family

ID=41417396

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201100001A EA201100001A3 (ru) 2008-06-11 2009-06-11 Нуклеотиды и нуклеозиды и методы их использования в секвенировании днк

Country Status (15)

Country Link
US (4) US8148503B2 (ru)
EP (1) EP2307565B1 (ru)
JP (1) JP5143953B2 (ru)
KR (1) KR101677772B1 (ru)
CN (2) CN103588839B (ru)
AU (1) AU2009257369B2 (ru)
BR (1) BRPI0915173B8 (ru)
CA (2) CA2979146C (ru)
EA (1) EA201100001A3 (ru)
HK (1) HK1163184A1 (ru)
IL (1) IL209917A (ru)
MX (1) MX2010013678A (ru)
NZ (2) NZ590265A (ru)
WO (1) WO2009152353A2 (ru)
ZA (1) ZA201100122B (ru)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897737B2 (en) 2006-12-05 2011-03-01 Lasergen, Inc. 3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
US8148503B2 (en) 2008-06-11 2012-04-03 Lasergen, Inc. Nucleotides and nucleosides and methods for their use in DNA sequencing
CN102292635B (zh) * 2008-09-22 2015-04-01 霍夫曼-拉罗奇有限公司 微阵列底物上的生物材料的选择性处理
CN103282518B (zh) * 2010-12-17 2016-11-16 纽约哥伦比亚大学理事会 使用经修饰的核苷酸和纳米孔检测的dna边合成边测序
KR102048274B1 (ko) * 2011-09-13 2019-11-25 애질런트 테크놀로지스, 인크. 핵산 시퀀싱을 위하여 5-메톡시, 3'-oh 차단안된, 신속하게 광절단가능한 종료 뉴클레오티드 및 핵산 시퀀싱 방법
EP2850514A4 (en) * 2012-05-18 2016-03-02 Univ Georgetown METHOD AND SYSTEMS FOR FACILITATING AND SEARCHING A DATABASE OF INFORMATION ON MEDICINAL PRODUCTS
US9146248B2 (en) 2013-03-14 2015-09-29 Intelligent Bio-Systems, Inc. Apparatus and methods for purging flow cells in nucleic acid sequencing instruments
EP2970365A4 (en) * 2013-03-15 2016-11-02 Ibis Biosciences Inc PHOTOCLELECTIVE DEOXYNUCLEOTIDES WITH HIGH RESOLUTION CONTROL OF DEPROTECTION KINETICS
US9591268B2 (en) 2013-03-15 2017-03-07 Qiagen Waltham, Inc. Flow cell alignment methods and systems
EP2970366B1 (en) * 2013-03-15 2019-01-16 Ibis Biosciences, Inc. Nucleotide analogs for sequencing
WO2015167620A1 (en) * 2014-04-29 2015-11-05 Biosearch Technologies, Inc. Compounds compositions and methods including thermally labile moieties
US10544455B2 (en) 2014-10-03 2020-01-28 Life Technologies Corporation Sequencing methods, compositions and systems using terminator nucleotides
US10487357B2 (en) 2014-10-03 2019-11-26 Life Technologies Corporation Methods of nucleic acid analysis using terminator nucleotides
WO2016065145A2 (en) 2014-10-22 2016-04-28 The Johns Hopkins University Psma targeted reversed carbamates and methods of use thereof
WO2016094845A2 (en) 2014-12-12 2016-06-16 Woolf Tod M Compositions and methods for editing nucleic acids in cells utilizing oligonucleotides
CN107949790A (zh) 2015-08-06 2018-04-20 激光基因公司 使用光可裂解标记进行抗原检测
CN108603227A (zh) 2015-11-18 2018-09-28 卡利姆·U·米尔 超分辨率测序
EP4372102A2 (en) 2016-06-06 2024-05-22 RedVault Biosciences, LP Target reporter constructs and uses thereof
US11371087B2 (en) * 2016-06-10 2022-06-28 Takara Bio Usa, Inc. Methods and compositions employing blocked primers
GB2559117B (en) * 2017-01-19 2019-11-27 Oxford Nanopore Tech Ltd Double stranded polynucleotide synthesis method, kit and system
CN108752406A (zh) * 2018-05-29 2018-11-06 苏州百源基因技术有限公司 一种荧光标记的核苷酸及其制备方法和用途
WO2020146312A1 (en) 2019-01-07 2020-07-16 Agilent Technologies, Inc. Compositions and methods for genomic dna and gene expression analysis in single cells
JP2023518730A (ja) * 2020-03-26 2023-05-08 アジレント・テクノロジーズ・インク 多段階プライマー伸長反応用の方法および組成物
CN113341058A (zh) * 2021-06-09 2021-09-03 南京溯远基因科技有限公司 一种三色高通量测序试剂及测序方法
AU2021453871A1 (en) 2021-06-29 2024-01-25 Agilent Technologies, Inc. Polymerase mutants and use with 3'-oh unblocked reversible terminators
EP4368628A1 (en) 2021-07-05 2024-05-15 Japan Science and Technology Agency Method for purifying nucleotides, device for purifying nucleotides, hydrophobic reagent, and hydrophobic substrate

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2136624A1 (de) 1971-07-22 1973-02-08 Boehringer Mannheim Gmbh N (6)-substituierte adenosin-derivate und verfahren zur herstellung derselben
US4318846A (en) 1979-09-07 1982-03-09 Syva Company Novel ether substituted fluorescein polyamino acid compounds as fluorescers and quenchers
US4439356A (en) 1981-03-03 1984-03-27 Syva Company Unsymmetrical fluorescein derivatives
DE3406533A1 (de) 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
US4657897A (en) 1984-06-22 1987-04-14 Warner-Lambert Company N6 -substituted adenosines for treating pain
US5151507A (en) 1986-07-02 1992-09-29 E. I. Du Pont De Nemours And Company Alkynylamino-nucleotides
JP2527340B2 (ja) 1986-12-15 1996-08-21 アプライド バイオシステムズ インコーポレイテッド ロ―ダミン染料の５−及び６−スクシニミジルカルボキシレ―ト異性体
US5824796A (en) 1988-09-28 1998-10-20 Epoch Pharmaceuticals, Inc. Cross-linking oligonucleotides
USRE38416E1 (en) 1988-09-28 2004-02-03 Epoch Biosciences, Inc. Cross-linking oligonucleotides
US5302509A (en) 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
US5366860A (en) 1989-09-29 1994-11-22 Applied Biosystems, Inc. Spectrally resolvable rhodamine dyes for nucleic acid sequence determination
US5188934A (en) 1989-11-14 1993-02-23 Applied Biosystems, Inc. 4,7-dichlorofluorescein dyes as molecular probes
GB9208733D0 (en) 1992-04-22 1992-06-10 Medical Res Council Dna sequencing method
WO1995002604A1 (en) 1993-07-13 1995-01-26 The United States Of America, Represented By The Secretary, Department Of Health And Human Services A3 adenosine receptor agonists
GB9315847D0 (en) 1993-07-30 1993-09-15 Isis Innovation Tag reagent and assay method
US5808045A (en) 1994-09-02 1998-09-15 Andrew C. Hiatt Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides
US6214987B1 (en) 1994-09-02 2001-04-10 Andrew C. Hiatt Compositions for enzyme catalyzed template-independent formation of phosphodiester bonds using protected nucleotides
US5872244A (en) 1994-09-02 1999-02-16 Andrew C. Hiatt 3' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds
US5763594A (en) 1994-09-02 1998-06-09 Andrew C. Hiatt 3' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds
US5684142A (en) 1995-06-07 1997-11-04 Oncor, Inc. Modified nucleotides for nucleic acid labeling
US5614386A (en) 1995-06-23 1997-03-25 Baylor College Of Medicine Alternative dye-labeled primers for automated DNA sequencing
US5861287A (en) 1995-06-23 1999-01-19 Baylor College Of Medicine Alternative dye-labeled primers for automated DNA sequencing
WO1997000967A1 (en) 1995-06-23 1997-01-09 Baylor College Of Medicine Alternative dye-labeled primers, ribonucleotides, deoxyribonucleotides, and dideoxyribonucleotides for automated dna analysis and homogeneous amplification/detection assays
US5994063A (en) 1995-06-23 1999-11-30 Metzker; Michael L. Substituted 4,4-difluoro-4-bora-3A,4A-diaza-s-indacene compounds for homogenous amplification/detection assays
US5728529A (en) 1995-06-23 1998-03-17 Baylor College Of Medicine Alternative dye-labeled ribonucleotides, deoxyribonucleotides, and dideoxyribonucleotides for automated DNA analysis
ATE280177T1 (de) 1997-03-20 2004-11-15 Hoffmann La Roche Modifizierte primer
WO1998050047A1 (en) 1997-05-09 1998-11-12 Trustees Of The University Of Pennsylvania Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
AU3199699A (en) 1998-03-23 1999-10-18 Invitrogen Corporation Modified nucleotides and methods useful for nucleic acid sequencing
ES2264826T3 (es) * 1998-10-16 2007-01-16 Pfizer Inc. Derivados de adenina.
EP1141409B2 (en) 1998-12-14 2009-05-27 Pacific Biosciences of California, Inc. A kit and methods for nucleic acid sequencing of single molecules by polymerase synthesis
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
WO2001023610A2 (en) 1999-09-29 2001-04-05 Solexa Ltd. Polynucleotide sequencing
US6586413B2 (en) 1999-11-05 2003-07-01 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
EP1736478B1 (en) 2000-05-26 2015-07-22 IDENIX Pharmaceuticals, Inc. Methods and compositions for treating flaviviruses and pestiviruses
US6869764B2 (en) 2000-06-07 2005-03-22 L--Cor, Inc. Nucleic acid sequencing using charge-switch nucleotides
US6875751B2 (en) 2000-06-15 2005-04-05 Idenix Pharmaceuticals, Inc. 3′-prodrugs of 2′-deoxy-β-L-nucleosides
MY141594A (en) 2000-06-15 2010-05-14 Novirio Pharmaceuticals Ltd 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
GB0015727D0 (en) * 2000-06-27 2000-08-16 Pfizer Ltd Purine derivatives
EP1368460B1 (en) 2000-07-07 2007-10-31 Visigen Biotechnologies, Inc. Real-time sequence determination
US7125660B2 (en) 2000-09-13 2006-10-24 Archemix Corp. Nucleic acid sensor molecules and methods of using same
WO2002029003A2 (en) 2000-10-06 2002-04-11 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding dna and rna
JP4195815B2 (ja) 2001-04-10 2008-12-17 ウペエフエル・エコル・ポリテクニック・フェデラル・ドゥ・ローザンヌ Ｏ６−アルキルグアニン−ｄｎａアルキルトランスフェラーゼ（ａｇｔ）の使用方法
US20030013675A1 (en) * 2001-05-25 2003-01-16 Boehringer Ingelheim Pharma Kg Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
ATE399790T1 (de) 2001-07-03 2008-07-15 Febit Biotech Gmbh Zweistufige schutzgruppen für die synthese von biopolymeren
US6995841B2 (en) 2001-08-28 2006-02-07 Rice University Pulsed-multiline excitation for color-blind fluorescence detection
GB0128526D0 (en) 2001-11-29 2002-01-23 Amersham Pharm Biotech Uk Ltd Nucleotide analogues
US7057026B2 (en) 2001-12-04 2006-06-06 Solexa Limited Labelled nucleotides
US20030180769A1 (en) 2002-02-05 2003-09-25 Metzker Michael L. Substituted 4,4-difluoro-4-bora-3A,4A-diaza-s-indacene compounds for 8-color DNA sequencing
US20040014096A1 (en) 2002-04-12 2004-01-22 Stratagene Dual-labeled nucleotides
GB2395953A (en) 2002-08-23 2004-06-09 Solexa Ltd Labelled nucleotides
US7414116B2 (en) 2002-08-23 2008-08-19 Illumina Cambridge Limited Labelled nucleotides
SI3002289T1 (en) 2002-08-23 2018-07-31 Illumina Cambridge Limited MODIFIED NUCLEOTES FOR POLYUCULOTIDE SEQUENCING
CZ294538B6 (cs) 2002-12-30 2005-01-12 Ústav Experimentální Botaniky Akademie Vědčeské Re Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
US7417139B2 (en) 2003-08-30 2008-08-26 Agilent Technologies, Inc. Method for polynucleotide synthesis
US7427679B2 (en) 2003-08-30 2008-09-23 Agilent Technologies, Inc. Precursors for two-step polynucleotide synthesis
US7193077B2 (en) 2003-08-30 2007-03-20 Agilent Technologies, Inc. Exocyclic amine triaryl methyl protecting groups in two-step polynucleotide synthesis
EP1725572B1 (de) 2003-11-05 2017-05-31 AGCT GmbH Makromolekulare nukleotidverbindungen und methoden zu deren anwendung
WO2005084367A2 (en) 2004-03-03 2005-09-15 The Trustees Of Columbia University In The City Of New York Photocleavable fluorescent nucleotides for dna sequencing on chip constructed by site-specific coupling chemistry
US7476734B2 (en) 2005-12-06 2009-01-13 Helicos Biosciences Corporation Nucleotide analogs
DK1848718T3 (da) * 2005-02-04 2012-08-27 Millennium Pharm Inc E1 aktiveringsenzymhæmmere
GB0517097D0 (en) 2005-08-19 2005-09-28 Solexa Ltd Modified nucleosides and nucleotides and uses thereof
MX338089B (es) * 2006-12-05 2016-04-01 Lasergen Inc Nucleotidos y necleosidos marcados de foto-escision y necleotidos y necleosidos marcados y metodos para su uso en secuenciacion de adn.
US7897737B2 (en) * 2006-12-05 2011-03-01 Lasergen, Inc. 3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
US7893227B2 (en) 2006-12-05 2011-02-22 Lasergen, Inc. 3′-OH unblocked nucleotides and nucleosides base modified with non-cleavable, terminating groups and methods for their use in DNA sequencing
US8148503B2 (en) 2008-06-11 2012-04-03 Lasergen, Inc. Nucleotides and nucleosides and methods for their use in DNA sequencing

Also Published As

Publication number Publication date
EP2307565A2 (en) 2011-04-13
JP5143953B2 (ja) 2013-02-13
US8148503B2 (en) 2012-04-03
WO2009152353A3 (en) 2013-09-26
CA2979146A1 (en) 2009-12-17
MX2010013678A (es) 2011-02-24
CN102264917A (zh) 2011-11-30
IL209917A0 (en) 2011-02-28
US8497360B2 (en) 2013-07-30
BRPI0915173B1 (pt) 2021-05-04
CA2727709C (en) 2017-11-14
US20140051848A1 (en) 2014-02-20
CA2979146C (en) 2020-07-07
CN102264917B (zh) 2015-06-10
EP2307565B1 (en) 2017-11-29
US8877905B2 (en) 2014-11-04
CN103588839B (zh) 2017-04-12
IL209917A (en) 2014-06-30
WO2009152353A2 (en) 2009-12-17
US20150140559A1 (en) 2015-05-21
ZA201100122B (en) 2013-09-25
AU2009257369A1 (en) 2009-12-17
US20100041041A1 (en) 2010-02-18
KR20110031191A (ko) 2011-03-24
CN103588839A (zh) 2014-02-19
CA2727709A1 (en) 2009-12-17
HK1163184A1 (en) 2012-09-07
KR101677772B1 (ko) 2016-11-18
NZ594812A (en) 2012-12-21
BRPI0915173A2 (pt) 2015-08-18
BRPI0915173B8 (pt) 2021-05-25
JP2011529449A (ja) 2011-12-08
US9200319B2 (en) 2015-12-01
NZ590265A (en) 2012-11-30
EA201100001A2 (ru) 2012-10-30
US20130035237A1 (en) 2013-02-07
AU2009257369B2 (en) 2015-03-26

Similar Documents

Publication Publication Date Title
EA201100001A2 (ru) Нуклеотиды и нуклеозиды и методы их использования в секвенировании днк
EA201490534A1 (ru) Способы мечения днк-кодированных библиотек
ATE502122T1 (de) Chemisch modifizierte oligonukleotidprimer zur nukleinsäureamplifikation
BR112014007852A2 (pt) nucleosídeos, nucleotídeos e ácidos nucleicos modificados e usos dos mesmos
EA201200217A1 (ru) Рнк с комбинацией из немодифицированных и модифицированных нуклеотидов для экспрессии белков
WO2009092035A3 (en) Methods and compositions for the analysis of biological molecules
MX2016007541A (es) Moléculas modificadas de ácido nucleico y usos de las mismas.
ATE533838T1 (de) Verfahren zur verbesserten einführung von dna in bakterienzellen
TR201815882T4 (tr) Tal efektörü aracılı dna modifikasyonu.
WO2009102896A3 (en) Isothermal nucleic acid amplification methods and compositions
UY31861A (es) Inmunoglobulina con dominio variable dual y usos de la misma
EA201170933A1 (ru) Анализ нуклеиновых кислот, полученных из единичных клеток
HK1243460A1 (zh) 產生單一序列dna探針的方法和組合物、dna探針的標記和這些探針的用途
CY1110860T1 (el) Αναστροφη μεταγραφαση τελομερασης πτηνου
WO2008069906A3 (en) Digital expression of gene analysis
WO2009124255A3 (en) Methods for transcript analysis
WO2006104913A3 (en) USE OF ANTI-TNF OR ANTI-ILl RNAI TO SUPPRESS PRO- INFLAMMATORY CYTOKINE ACTIONS LOCALLY TO TREAT PAIN
EP2350670A4 (en) INTO A MEMBRANE INTEGRATED PROTEIN CONNECTOR BIOSENSOR FOR VIRAL DNA PACKAGING ENGINES FOR DNA SEQUENCING AND OTHER USES
MX2010001490A (es) Acidos nucleicos de enlace sdf-1 y uso de los mismos.
WO2009014612A3 (en) Modified nucleotides, methods for making and using same
WO2014052487A8 (en) Two-primer pcr for microrna multiplex assay
ATE505562T1 (de) Doppel-oligonukleotid- nukleinsäurenachweisverfahren
WO2011029008A3 (en) Synbodies to akt1
WO2010059323A3 (en) Sequence amplification with target primers
IN2012DN00172A (ru)